Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (9) | Back to Search
Recommendations & Regulatory actions on drugs: Based on Pharmacovigilance Programme of India (PvPI) data.
- In: Poster presentation
- At: Buenos Aires (Argentina) (2016)
- Type: Poster
- Poster code: POS-HMIS-017
- By: KUMAR, Pranay (Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Govt. of India, Pharmacovigilance, Ghaziabad, India)
- Co-author(s): Pranay Kumar:,Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Govt. of India,Ghaziabad,India|V. Kalai selvan:,Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Govt. of India,Ghaziabad,India|Prabhakar Mishra:,Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Govt. of India,Ghaziabad,India|Ismeet Kaur:,Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Govt. of India,Ghaziabad,India|G. N. Singh:,Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Govt. of India,Ghaziabad,India
- Abstract:
Ministry of Health & Family Welfare, Govt. of India launched nationwide Pharmacovigilance Programme of India to monitor the Adverse Drug Reactions (ADRs) in Indian population and to provide scientific support to Central Drugs Standard Control Organization (CDSCO) to take appropriate regulatory decisions.
Statistical method used in the analysis of
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023